Sign In
Buy MPW
$5.02
+0 (+0%)
At Close: May 01, 2026
Medical Properties (MPW) Q3 FFO and Revenues Miss Estimates
10:11am, Thursday, 30'th Oct 2025
Medical Properties (MPW) came out with quarterly funds from operations (FFO) of $0.13 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to FFO of $0.16 per share a year
Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates
08:00am, Thursday, 30'th Oct 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the third quarter ended September 30,
Medical Properties Trust has replaced its troubled tenants with healthier ones. The REIT has also firmed up its financial foundation.
Medical Properties Trust: Recent Asset Sales Prove The Shorts Are Wrong
05:49pm, Thursday, 23'rd Oct 2025
Medical Properties Trust (MPW) is significantly undervalued, with recent asset sales and settlements de-risking its portfolio and supporting a bullish outlook. Recent hospital sales to HonorHealth and
Medical Properties Trust: Don't Ignore Leverage, Reiterate 'Strong Sell'
05:48pm, Thursday, 23'rd Oct 2025
Medical Properties Trust faces ongoing risks from high tenant concentration and a substantial debt load, despite the recent recovery in its stock price. MPW's leverage remains elevated at 9.6x net deb
Medical Properties Trust Announces Third Quarter 2025 Financial Results Conference Call and Webcast
04:15pm, Thursday, 23'rd Oct 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced it will host a conference call and webcast on Thursday, October 30, 2025,
MPW Still Trades At A Discount To Book Value, Maintain Hold
08:45am, Wednesday, 22'nd Oct 2025
Medical Properties Trust shows signs of operational recovery, with Q2 results highlighting improved rental income and strategic capital management. MPW's turnaround is driven by new tenants, refinanci
Medical Properties Trust, Inc. $MPW Stake Lessened by Vanguard Personalized Indexing Management LLC
03:56am, Wednesday, 22'nd Oct 2025
Vanguard Personalized Indexing Management LLC decreased its holdings in shares of Medical Properties Trust, Inc. (NYSE: MPW) by 4.5% in the undefined quarter, according to the company in its most rece
Medical Properties (MPW) Beats Stock Market Upswing: What Investors Need to Know
06:51pm, Monday, 20'th Oct 2025
Medical Properties (MPW) concluded the recent trading session at $5.22, signifying a +1.56% move from its prior day's close.
Medical Properties (MPW) Just Overtook the 20-Day Moving Average
10:35am, Wednesday, 15'th Oct 2025
Medical Properties (MPW) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MPW crossed above the 20-day moving average, suggest
Medical Properties (MPW) Ascends While Market Falls: Some Facts to Note
06:51pm, Tuesday, 14'th Oct 2025
Medical Properties (MPW) reached $5.22 at the closing of the latest trading day, reflecting a +1.56% change compared to its last close.
Here is What to Know Beyond Why Medical Properties Trust, Inc. (MPW) is a Trending Stock
10:01am, Tuesday, 14'th Oct 2025
Zacks.com users have recently been watching Medical Properties (MPW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Key Reasons to Add Medical Properties Stock to Your Portfolio
11:45am, Monday, 13'th Oct 2025
MPW's long-term leases, capital recycling and solid balance sheet make it a compelling addition to any portfolio.
Mousetraps: 6 High-Yield REITs Risking Dividend Cuts
04:35pm, Friday, 10'th Oct 2025
High-yield REITs with low Dividend Safety grades often signal an elevated risk of dividend cuts and rapid share price declines, making them potential "mousetraps" for income investors. This article hi
Medical Properties (MPW) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 09'th Oct 2025
Medical Properties (MPW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
